Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Surgery plus adjuvant chemotherapy--a review of therapeutic implications. I. Breast cancer.

× No keyword cloud information.

22 in total

1. Integration of chemotherapy into combined modality treatment of solid tumors VII. Adenocarcinoma of the breast.

Authors: S K Carter
Journal: Cancer Treat Rev Date: 1976-09 Impact factor: 12.111

2. 1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.

Authors: B Fisher; P Carbone; S G Economou; R Frelick; A Glass; H Lerner; C Redmond; M Zelen; P Band; D L Katrych; N Wolmark; E R Fisher
Journal: N Engl J Med Date: 1975-01-16 Impact factor: 91.245

3. Extended surgical adjuvant thiotepa for mammary carcinoma.

Authors: W L Donegan
Journal: Arch Surg Date: 1974-08

4. Association between steroid hormone receptor status and disease-free interval in breast cancer.

Authors: J C Allegra; M E Lippman; R Simon; E B Thompson; A Barlock; L Green; K K Huff; H M Do; S C Aitken; R Warren
Journal: Cancer Treat Rep Date: 1979-08

5. Surgical adjuvant chemotherapy: results with one short course with cyclophosphamide after mastectomy for breast cancer.

Authors: R Nissen-Meyer; K Kjellgren; K Malmio; B Månsson; T Norin
Journal: Cancer Date: 1978-06 Impact factor: 6.860

6. Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication.

Authors: J S Meyer; B R Rao; S C Stevens; W L White
Journal: Cancer Date: 1977-11 Impact factor: 6.860

7. Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy.

Authors: B Fisher; N Slack; D Katrych; N Wolmark
Journal: Surg Gynecol Obstet Date: 1975-04

8. Relationship between proliferative activity and estrogen receptors in breast cancer.

Authors: R Silverstrini; M G Daidone; G Di Fronzo
Journal: Cancer Date: 1979-08 Impact factor: 6.860

9. Advanced stage and early relapse of breast carcinomas associated with high thymidine labeling indices.

Authors: J S Meyer; B Hixon
Journal: Cancer Res Date: 1979-10 Impact factor: 12.701

10. Ovarian function in patients receiving adjuvant chemotherapy for breast cancer.

Authors: D P Rose; T E Davis
Journal: Lancet Date: 1977-06-04 Impact factor: 79.321

7 in total

1. Choosing treatment for metastatic breast cancer.

Authors:
Journal: Br Med J (Clin Res Ed) Date: 1983-01-15

2. Adjuvant use of cytotoxic chemotherapy to destroy micrometastasis in breast cancer after local control therapy--current status.

Authors: S K Carter
Journal: Clin Exp Metastasis Date: 1983 Jan-Mar Impact factor: 5.150

3. Possible adverse effect of failed adjuvant chemotherapy on the prognosis of women receiving consecutive chemotherapy for recurrent breast cancer.

Authors: C Dittrich; R Jakesz; K Pirich; L Havelec; G Steger; O Schlappack; R Kolb; K Moser
Journal: J Cancer Res Clin Oncol Date: 1987 Impact factor: 4.553

4. Adjuvant chemotherapy of breast cancer: hope--reality--hazard?

Authors: H Vorherr
Journal: Klin Wochenschr Date: 1984-02-15

5. Multimodal treatment in operable breast cancer: five-year results of the CMF programme.

Authors: A Rossi; G Bonadonna; P Valagussa; U Veronesi
Journal: Br Med J (Clin Res Ed) Date: 1981-05-02

6. 2nd Gordon Hamilton Fairley lecture. Need for new approaches to the treatment of patients in clinical remission, with special reference to acute myeloid leukaemia.

Authors: P Alexander
Journal: Br J Cancer Date: 1982-08 Impact factor: 7.640

7. Preliminary results of primary systemic chemotherapy in association with surgery or radiotherapy in rapidly progressing breast cancer.

Authors: N Mourali; F Tabbane; L R Muenz; J Bahi; S Belhassen; L S Kamaraju; P H Levine
Journal: Br J Cancer Date: 1982-03 Impact factor: 7.640

7 in total